Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
WORKING PAPERS
April 11, 2024
POLICY PAPERS
April 15, 2024
CGD NOTES
April 08, 2024
WORKING PAPERS
April 04, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
WORKING PAPERS
August 19, 2009
Before a 2006 UN Special Session proclaimed there should be universal access to antiretrovirals (ARV), the life-saving drugs were far too expensive for most people with AIDS. In a new CGD working paper, Ethan Kapstein and Josh Busby examine how activists transformed ARVs from expensive private good...
WORKING PAPERS
February 13, 2009
Senior fellow Mead Over estimates the effect of AIDS on poverty in South Asia and analyzes public policy options to help the region’s predominantly private health care systems meet the challenge of treating AIDS. He finds that South Asian governments should play a larger role in AIDS treatment th...
WORKING PAPERS
January 05, 2009
The debate on user fees in health and education has been contentious, but until recently much of the evidence has been anecdotal. Does charging poor people for health and education services improve or impede access? CGD non-resident fellow Michael Kremer and co-author Alaka Holla survey the evidence...
WORKING PAPERS
May 05, 2008
U.S. global AIDS spending is helping to prolong the lives of more than a million people, yet this success contains the seeds of a future crisis. Escalating treatment costs coupled with neglected prevention measures mean that AIDS spending is growing so rapidly that it threatens to squeeze out U.S. s...
WORKING PAPERS
October 15, 2007
This week, public health advocates gather in London to mark the 20th anniversary of the global safe motherhood initiative, launched in 1987 to reduce the number of mothers who die or suffer injury giving birth. Despite the advocates' work, the initiative has yet to gain the political traction needed...
WORKING PAPERS
July 06, 2005
We consider how patent rights and price regulation affect whether new drugs are marketed in a country, and how quickly. The analysis covers a large sample of 68 countries at all income levels and includes all drug launches over the period 1982-2002. It uses newly compiled information on legal and re...